Top Suppliers:I want be here

166388-57-4

166388-57-4 structure
166388-57-4 structure
  • Name: Azido-PEG2-C2-amine
  • Chemical Name: 2-[2-(2-azidoethoxy)ethoxy]ethanamine
  • CAS Number: 166388-57-4
  • Molecular Formula: C6H14N4O2
  • Molecular Weight: 174.20100
  • Catalog: Chemical reagent Organic reagent Azide
  • Create Date: 2019-02-04 12:06:26
  • Modify Date: 2024-01-02 12:05:23
  • Azido-PEG2-C2-amine (N3-PEG2-CH2CH2NH2) is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. Azido-PEG2-C2-amine is also a non-cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs)[2].

Name 2-[2-(2-azidoethoxy)ethoxy]ethanamine
Synonyms 2-(2-(2-azidoethoxy)exthoxy)ethanamine
1-AMINO-8-AZIDO-3,5-DIOXAOCTANE
Amino-PEG2-Azide
2-azidoethyloxyethyloxyethylamine
2-(2-(2-azidoethoxy)ethoxy)ethanamine
1-(2-AMINOETHOXY)-2-(2-AZIDOETHOXY)ETHANE
2-[2-(2-azidoethoxy)-ethoxy]-ethylamine
Description Azido-PEG2-C2-amine (N3-PEG2-CH2CH2NH2) is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. Azido-PEG2-C2-amine is also a non-cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs)[2].
Related Catalog
Target

PEGs

Non-cleavable

In Vitro PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins[1]. ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker[2].
References

[1]. Su S, et al. Potent and Preferential Degradation of CDK6 via Proteolysis Targeting Chimera Degraders. J Med Chem. 2019 Aug 22;62(16):7575-7582.

[2]. Tominari, Yusuk , et al. Heterocyclic compound. WO2020027225A1.

Molecular Formula C6H14N4O2
Molecular Weight 174.20100
Exact Mass 174.11200
PSA 94.23000
LogP 0.44166
Storage condition 2-8°C

~99%

166388-57-4 structure

166388-57-4

Literature: Klein, Emmanuel; DeBonis, Salvatore; Thiede, Bernd; Skoufias, Dimitrios A.; Kozielski, Frank; Lebeau, Luc Bioorganic and Medicinal Chemistry, 2007 , vol. 15, # 19 p. 6474 - 6488

~76%

166388-57-4 structure

166388-57-4

Literature: Li, Ying; Schaffer, Paul; Perrin, David M. Bioorganic and Medicinal Chemistry Letters, 2013 , vol. 23, # 23 p. 6313 - 6316

~57%

166388-57-4 structure

166388-57-4

Literature: Lu, Yan; Gervay-Hague, Jacquelyn Carbohydrate Research, 2007 , vol. 342, # 12-13 p. 1636 - 1650

~%

166388-57-4 structure

166388-57-4

Literature: Bioorganic and Medicinal Chemistry Letters, , vol. 17, # 6 p. 1499 - 1503

~%

166388-57-4 structure

166388-57-4

Literature: Zheng, Hong; Wang, Fang; Wang, Qin; Gao, Jianmin Journal of the American Chemical Society, 2011 , vol. 133, # 39 p. 15280 - 15283

~%

166388-57-4 structure

166388-57-4

Literature: Carbohydrate Research, , vol. 342, # 12-13 p. 1636 - 1650

~%

166388-57-4 structure

166388-57-4

Literature: Journal of the American Chemical Society, , vol. 133, # 39 p. 15280 - 15283

~%

166388-57-4 structure

166388-57-4

Literature: Journal of the American Chemical Society, , vol. 134, # 45 p. 18809 - 18815

~%

166388-57-4 structure

166388-57-4

Literature: Journal of the American Chemical Society, , vol. 134, # 45 p. 18809 - 18815